Opinion|Videos|December 23, 2024

Infection Prevention and Leveraging EHR for Bispecific Therapy Management

Panelists discuss insights on infection prevention protocols and electronic health record (EHR)–based toxicity management strategies for patients receiving bispecific antibody therapies in relapsed/refractory multiple myeloma (RRMM).

Video content above is prompted by the following

  • What best practices can you share regarding preventing infection in patients receiving bispecific therapies in RRMM?
  • How has your institution leveraged the electronic health record to assist with standardization and management of toxicities seen with bispecific therapies?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME